Salt la conţinut

Drepanocitoză

Managementul pacienţilor cu potenţial chirurgical

Erythropoietin therapy for sickle cell anemia in Jehovah's Witnesses. (se deschide o fereastră nouă)

Brooks BJ Jr, Hanson DS, Cryer PA, Hubbard WJ, Hooper D.

Sursă‎: South Med J 1991;84(11):1416-7.

Index‎: PubMed 1948247

https://www.ncbi.nlm.nih.gov/pubmed/1948247 (se deschide o fereastră nouă)

Hydroxycarbamide and erythropoietin in the preoperative management of children with sickle cell anaemia undergoing moderate risk surgery. (se deschide o fereastră nouă)

Furness CL, O'Driscoll S, Davenport M, Morrison G, Height SE, Dick MC, Rees DC.

Sursă‎: Br J Haematol 2009;144(3):453-4.

Index‎: PubMed 19036093

DOI‎: 10.1111/j.1365-2141.2008.07463.x

https://www.ncbi.nlm.nih.gov/pubmed/19036093 (se deschide o fereastră nouă)

Impact of hydroxyurea on perioperative management and outcomes in children with sickle cell anemia. (se deschide o fereastră nouă)

Hayashi M, Calatroni A, Herzberg B, Ross AK, Rice HE, Thornburg C.

Sursă‎: J Pediatr Hematol Oncol 2011;33(7):487-90.

Index‎: PubMed 21941139

DOI‎: 10.1097/MPH.0b013e318230b2f4

https://www.ncbi.nlm.nih.gov/pubmed/21941139 (se deschide o fereastră nouă)

Tourniquet use during total knee replacement in a Jehovah's Witness with sickle cell trait: a case report. (se deschide o fereastră nouă)

Siddiqui FM, Slater RM, Razzaq I, Atkinson M, Ryan K.

Sursă‎: Eur J Anaesthesiol 2010;27(6):581-2.

Index‎: PubMed 20299991

DOI‎: 10.1097/EJA.0b013e328334f16e

https://www.ncbi.nlm.nih.gov/pubmed/20299991 (se deschide o fereastră nouă)